ArticleBone marrow transplantation2026
Sequential CD19/CD22 CAR-T cell therapy following ASCT shows improved efficacy versus CAR-T alone in relapsed/refractory large B-cell lymphoma.
Jiaqi Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.